Highlighting Exosome-Driven Therapeutic Mechanisms of Deramiocel, an Allogeneic Cardiac-Derived Cell Therapy

• Exploring recent update of deramiocel Phase 3 trial
• Reviewing direct evidence deramiocel exosome homing to skeletal muscle
• Understanding MOA of exosome on anti-fibrosis, anti-inflammatory and potential targeting mechanism

Speakers:

Minghao Sun

Senior Vice President of Product Development, Quality Control & R&D

Capricor Therapeutics